Antipsychotic-Induced Movement Disorders in the Elderly
- 1 November 2000
- journal article
- review article
- Published by Springer Nature in Drugs & Aging
- Vol. 17 (5) , 363-384
- https://doi.org/10.2165/00002512-200017050-00004
Abstract
We reviewed the epidemiological aspects of antipsychotic-induced movement disorders as they pertain to older patients. The incidence and prevalence of drug-induced parkinsonism and tardive dyskinesia...Keywords
This publication has 164 references indexed in Scilit:
- What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using DysportJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Treatment of Tardive DyskinesiaSchizophrenia Bulletin, 1997
- Pharmacological Options for the Management of DyskinesiasDrugs, 1996
- Prevalence of dystonia in veterans on chronic antipsychotic therapyMovement Disorders, 1990
- Reduced glutamate decarboxylase activity in the subthalamic nucleus in patients with tardive dyskinesiaMovement Disorders, 1989
- ALPHA-TOCOPHEROL IN TARDIVE DYSKINESIAThe Lancet, 1987
- Plasma Level Monitoring of Antipsychotic Drugs Clinical UtilityClinical Pharmacokinetics, 1986
- Pharmacokinetics in the aged: A reviewJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Extrapyramidal Disorders After Prolonged Phenothiazine TherapyThe British Journal of Psychiatry, 1971
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970